Jaguar Gene Therapy
Signal active
Organization
Contact Information
Overview
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
About
Industries
Biotechnology, Genetics, Product Research
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Jaguar Gene Therapy headquartered in United States, North America, operates in the Biotechnology, Genetics, Product Research sector. The company focuses on Biotechnology and has secured $5.0B in funding across 36 round(s). With a team of 11-50 employees, Jaguar Gene Therapy is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Jaguar Gene Therapy, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
2
Lead Investors
0
Total Funding Amount
$139.0M
Details
2
Jaguar Gene Therapy has raised a total of $139.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 139.0M | ||
| 2021 | Early Stage Venture |
Investors
Jaguar Gene Therapy is funded by 17 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Samsung Ventures | - | FUNDING ROUND - Samsung Ventures | undefined |
| Katie Ellias | - | FUNDING ROUND - Katie Ellias | undefined |
| Jaguar Gene Therapy | - | FUNDING ROUND - Jaguar Gene Therapy | undefined |
| JDRF T1D Fund | - | FUNDING ROUND - JDRF T1D Fund | undefined |
Recent Activity
There is no recent news or activity for this profile.